The industrial microbiology market has seen considerable growth due to a variety of factors.
•Over the past years, significant growth has been observed in the size of the industrial microbiology market. With a projected increase from $15.43 billion in 2024 to $16.48 billion in 2025, it is expected to have a compound annual growth rate (CAGR) of 6.8%.
The expansion during the historic period is believed to be a result of the rising demand for biopharmaceuticals, the global reach of the pharmaceutical industry, emphasis on food safety, environmental supervision, and quality check in the beverage industry.
The industrial microbiology market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the size of the industrial microbiology market is predicted to experience robust growth, reaching a value of "$22.23 billion in 2029, with a compound annual growth rate (CAGR) of 7.8%.
This growth during the forecast period can be credited to factors like increased bioprocessing in the agricultural sector, the growing demand for personalized medicines, greater utilization in energy production, strict regulatory standards, and escalating global health concerns. The period is also expected to witness significant trends including the development of new biotechnologies, digitalization and automation, advancements in technology, personalized microbial solutions, as well as collaborations and partnerships.
The industrial microbiology market is set to flourish due to the rise in pharmaceutical production. Activities in pharmaceutical production, such as manufacturing therapeutic products and medications through biological processes, biopharmaceutical techniques or chemical synthesis, are driving this growth. Factors leading to a surge in pharmaceutical production include the aging populace, regulatory modifications and health emergencies, which all bolster the demand for innovative treatments and medications. Industrial microbiology utilizes microbial fermentation to churn out a diverse set of pharmaceuticals in large quantities. These pharmaceuticals include antibiotics like penicillin, hormones like insulin, and vaccines, produced using microorganisms such as yeast, fungi, and bacteria. To illustrate, Eurostat, a Belgium governing body, reports that the EU's pharmaceutical production escalated from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, signifying a remarkable growth in the field. It hence follows that the rise in pharmaceutical production will fuel the expansion of the industrial microbiology market.
The industrial microbiology market covered in this report is segmented –
1) By Product: Equipment And Systems, Reaction Consumables, Laboratory Supplies
2) By Test: Sterility Testing, Microbial Limits Testing, Bio-Burden Testing, Water And Environmental Testing
3) By End-Use: Food And Beverages, Pharmaceutical Biotechnology, Agricultural, Environmental, Cosmetic And Personal Care, Other End-Uses
Subsegments:
1) By Equipment And Systems: Incubators, Autoclaves, Microbial Analyzers, Sterilizers, Automated Systems
2) By Reaction Consumables: Culture Media, Reagents and Chemicals, Growth Supplements
3) By Laboratory Supplies: Petri Dishes, Test Tubes, Pipettes, Filters, Gloves And Personal Protective Equipment (PPE)
The industrial microbiology market is significantly influenced by technological innovations. Key players in the market are focusing on implementing cutting-edge technologies to fortify their market stance. For instance, the medical technology firm based in the USA, Becton, Dickinson, and Company, launched the BD Kiestra IdentifA system in January 2022. It employs MALDI-ToF and automated colony technology to automate the preparation for microbiological bacterial identification testing. Using the BD Synapsys informatics, lab technicians can select unique bacterial colonies from a digital plate image with the help of the BD Kiestra IdentifA. Advanced robotics physically determine the chosen organisms and the sample is ready for specific identification testing. The BD Kiestra IdentifA minimizes the chances of human errors during sample preparation for bacterial identification, making procedures less manual and more time-efficient, leading to more precise diagnoses for patients.
Major companies operating in the industrial microbiology market include:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• The Merck Group
• Becton Dickinson and Company
• Asiagel Corporation
• Eppendorf Group
• bioMérieux SA
• Novamed Ltd.
• QIAGEN N.V.
• Sartorius AG
• 3M Company
• Agilent Technologies Inc.
• vermicon AG
• Eurofins Scientific SE
• MilliporeSigma
• Hardy Diagnostics
• Neogen Corporation
• HiMedia Laboratories
• BioConnections
• Biomerica Inc.
• Bruker Corporation
• Charles River Laboratories International Inc.
• GENEWIZ Inc.
• Luminex Corporation
• Microbiologics Inc.
• Promega Corporation
• Q Laboratories Inc.
• Rapid Micro Biosystems Inc.
• Shimadzu Corporation
• TSI Incorporated
North America was the largest region in the industrial microbiology market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global industrial microbiology market report during the forecast period. The regions covered in the industrial microbiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa